This inventor holds 4 USPTO granted patents. Top assignees: Applied Food Biotechnology, Inc., Zeavision LLC. Active years: 1998-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- St. Louis, MO (US) (1998)
- Morristown, NJ (US) (2010)
Company Filing History:
Years Active: 1998-2010
Title: Kevin M Garnett: Innovator in Zeaxanthin Formulations
Introduction
Kevin M Garnett is a notable inventor based in St. Louis, MO (US), recognized for his contributions to the field of nutritional science. He holds a total of four patents, focusing primarily on zeaxanthin formulations aimed at improving human health, particularly eye health.
Latest Patents
One of his latest patents is for zeaxanthin formulations for human ingestion. This invention involves a composition designed for oral ingestion, containing the R-R stereoisomer of zeaxanthin, which constitutes at least about 90 percent of the total zeaxanthin in the formulation. The patent outlines that the capsule or tablet must contain a sufficient quantity of the R-R stereoisomer to cause a detectable increase in zeaxanthin concentration in retinal tissue. This formulation can be incorporated into various food products, such as margarine and dairy items, and is aimed at treating and preventing eye diseases, including macular degeneration.
Another significant patent by Garnett is a method for making pure 3R-3'R stereoisomer of zeaxanthin for human consumption. This method ensures that the desired stereoisomer is the sole detectable form, produced using a specific strain of Flavobacterium multivorum cells. The process allows for the concentration and purification of zeaxanthin, making it suitable for therapeutic use in patients suffering from macular degeneration or as a nutritional supplement for those looking to reduce their risk of age-related eye diseases.
Career Highlights
Throughout his career, Garnett has worked with various companies, including Applied Food Biotechnology, Inc. and Zeavision LLC. His work has significantly impacted the field of nutritional supplements, particularly in the development of products aimed at enhancing eye health.
Collaborations
Garnett has collaborated with notable individuals in his field, including Dennis L Gierhart and Luis H Guerra-Santos. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.
Conclusion
Kevin M Garnett is a pioneering inventor whose work in zeaxanthin formulations has the potential to improve eye health for many individuals. His innovative approaches and patented methods reflect his commitment to advancing nutritional science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
